(Q37924989)

25 August 2017

1 reference

title

The role of molecular genetic analysis within the diagnostic haemato-oncology laboratory (English)

1 reference

25 August 2017

A J Bench

1

1 reference

25 August 2017

26 August 2011

1 reference

International Journal of Laboratory Hematology

25 August 2017

1 reference

25 August 2017

34

1 reference

25 August 2017

1

1 reference

25 August 2017

21-34

1 reference

Pyrosequencing: history, biochemistry and future

25 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Molecular genetic analysis of haematological malignancies II: Mature lymphoid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

A real-time polymerase chain reaction assay for rapid, sensitive, and specific quantification of the JAK2V617F mutation using a locked nucleic acid-modified oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leu

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Guideline for investigation and management of adults and children presenting with a thrombocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Use of denaturing HPLC for detection of mutations in the BCR-ABL kinase domain in patients resistant to Imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion/deletion polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Clinical correlates of JAK2V617F allele burden in essential thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

High resolution melting for mutation scanning of TP53 exons 5-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Coamplification at lower denaturation temperature-PCR increases mutation-detection selectivity of TaqMan-based real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Concordance of assays designed for the quantification of JAK2V617F: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Recurring mutations found by sequencing an acute myeloid leukemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

PCR-based methods for the enrichment of minority alleles and mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Comparison of BIOMED-2 versus laboratory-developed polymerase chain reaction assays for detecting T-cell receptor-gamma gene rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Denaturing high-performance liquid chromatography: a valid approach for identifying NPM1 mutations in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Evaluation of STR informativity for chimerism testing--comparative analysis of 27 STR systems in 203 matched related donor recipient pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

BRAF mutations in hairy-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Prognostically useful gene-expression profiles in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

High-resolution melting analysis for detection of internal tandem duplications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease--a study within the Europe Against Cancer Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Next-generation sequencing: from basic research to diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

The RSD code: proposal for a nomenclature of allelic configurations in STR-PCR-based chimerism testing after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2011.01364.X

10.1111/J.1751-553X.2011.01364.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21883966